Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Vorinostat CAS 149647-78-9

High Quality Antineoplastic Drugs Chemical Powder Vorinostat CAS 149647-78-9

 

  • Önümiň ady:

    Vorinostat CAS 149647-78-9

  • Baha:

    Pharmaceutical grade/Cosmetic grade

  • Aýratynlyklary:

    ak poroşok

  • Gaplamak:

    25 kg / deprek

  • MOQ:

    1 kilo

  • Saklama:Gurak ýer
  • Ýaramlylyk möhleti:2 ýyl


Jikme-jiklikler

Bellikler

Önümiň beýany

Vorinostat is a potent HDAC inhibitor with significant applications in cancer treatment, regulating gene expression, and potentially antiviral activities.

  1. HDAC Inhibition: Vorinostat functions by specifically binding to and inhibiting HDAC, including HDAC1, HDAC2, HDAC3 (Class I), and HDAC6 (Class II), thereby altering the acetylation status of histones and other proteins.
  2. Gene Expression Regulation: By inhibiting HDAC activity, Vorinostat helps to restore normal gene expression patterns, which are often disrupted in cancer cells. This leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells.
  3. Antiviral Activity: Studies have also shown that Vorinostat has the potential to reactivate latent HIV virus in patients, although further research is needed to fully understand and exploit this antiviral property in clinical settings.

 

 

Arza
  1. Anticancer Drug: Vorinostat is primarily utilized as an anticancer agent, particularly in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin's lymphoma that has worsened, persisted, or recurred after two systemic therapies.
  2. FDA Approval: It was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of skin cancer, marking it as the first FDA-approved drug for metastatic CTCL when other therapies have failed, the disease has worsened, or has returned.
  3. Combination Therapy: Vorinostat can also be used in combination with other antitumor drugs to enhance their synergistic effects.

 

Üstünlikleri

Çuňňur hyzmatdaşlygy bolan ýokary hilli önümler we bäsdeşlik bahalary bilen üpjün edip biljek köp sanly ýokary hilli zawodlarymyz bar. Şeýle hem, köpçülikleýin satyn almak üçin arzanladyş berip bileris. Köp hünärli ýük ekspeditor kompaniýalary bilen hyzmatdaşlyk edýäris, önümleri ygtybarly we rahat eliňize berip bileris. Eltip beriş wagty, töleg tassyklanandan 3-20 gün soň.

 

Spesifikasiýa

 

Ibermek we tölemek


 

Sorag-jogap

1. Siz zawodmy ýa-da söwda kompaniýasymy?
Biz bir bitewi hyzmaty hödürleýän senagaty we söwdany birleşdirýän birleşdiriji. OEM kabul edilip bilner.

2. Nusga berýärsiňizmi? Mugtmy ýa-da goşmaça?
Mugt nusgalar. Nusganyň ýük tölegini siziň tarapyňyz tölemeli.

3. Hil gözegçiligi bilen baglanyşykly şahadatnamalaryňyz barmy?
Hilini üpjün etmek üçin ISO 9001: 2008 kepilnamasy.

4. Sitata almak üçin näme bermeli?
Size zerur önümiň görnüşi, sargyt mukdary, salgysy we aýratyn talaplary barada habar beriň. Sitata salgylanma üçin wagtynda berler.

5. Haýsy töleg usulyny has gowy görýärsiňiz? Haýsy şertler kabul edilýär?
Kabul edilen gowşuryş şertleri: FOB, CFR, CIF, EXW;
Kabul edilen töleg walýutasy: USD;
Accepted Payment Type: T/T,Western Union; Paypal,BTC
Gepleşik dili: Iňlis.

 

Önümlerimiz bilen gyzyklanýan bolsaňyz, maglumatlaryňyzy şu ýerde goýup bilersiňiz, ýakyn wagtda siziň bilen habarlaşarys.


Habaryňyzy şu ýere ýazyň we bize iberiň